Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart H Burri

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Advances in Radiation Oncology|March 18, 2021
Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysisRoshan S Prabhu, Brandon E Turner, Anthony L Asher, et al.
The Lancet. Oncology|November 30, 2024
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trialJohn H Heinzerling, Kathryn F Mileham, Myra M Robinson, et al.
Research Square|March 30, 2023
Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRSCaroline S Jansen, Roshan S Prabhu, Meghana S Pagadala, et al.
Nature Communications|October 14, 2024
Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlatesCaroline S Jansen, Meghana S Pagadala, Maria A Cardenas, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Advances in Radiation Oncology|March 18, 2021
Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysisRoshan S Prabhu, Brandon E Turner, Anthony L Asher, et al.
The Lancet. Oncology|November 30, 2024
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trialJohn H Heinzerling, Kathryn F Mileham, Myra M Robinson, et al.
Research Square|March 30, 2023
Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRSCaroline S Jansen, Roshan S Prabhu, Meghana S Pagadala, et al.
Nature Communications|October 14, 2024
Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlatesCaroline S Jansen, Meghana S Pagadala, Maria A Cardenas, et al.
Pageof 6